Stifel analysts continue to favor staples, health care, utilities and telecom for 2019. These companies in those categories paid the highest dividends and their stocks look like solid picks for investors.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Apple, Apptio, Cheniere Energy, First Solar, Kratos Defense & Security Solutions, Smartsheet, UPS and Waste Management.
The top analyst upgrades, downgrades and initiations seen on Friday include Dollar Tree, Goldman Sachs, Palo Alto Networks, Sony and Under Armour.
The top analyst upgrades, downgrades and initiations seen from Wednesday included Abbott Laboratories, Boston Scientific, CME, DaVita, Skyworks Solutions, Spirit Airlines, Advanced Micro Devices and Nvidia.
These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices for worried investors to consider now.
The top analyst upgrades, downgrades and initiations seen on Thursday included Abbott Laboratories, Advanced Micro Devices, Alphabet, FireEye, Gap, Golar LNG and Nike.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Adobe, Bank of America, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX Companies and Valero Energy.
The top analyst upgrades, downgrades and initiations seen on Monday included Apple, Baker Hughes, Conagra Brands, Facebook, General Electric, Halliburton, Petrobras, Schlumberger, Vodafone and Walmart.
The top analyst upgrades, downgrades and initiations seen on Monday include Abbott Labs, Avon, Caesars, Comcast, Rowan, UnitedHealth and Vonage.
The top analyst upgrades, downgrades and other research calls from Wednesday include Alcoa, Cisco, eBay, IBM, Procter & Gamble, Square, Tesla, United Continental and Visa.
The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Abbott Laboratories, Honeywell, Tiffany and Zimmer Biomet.
Here are seven companies that have 50 straight years or more of raising their dividends, as well as several runners-up.
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Alphabet, Amazon.com, General Electric, Gilead Sciences, Intel, Seagate Technology and U.S. Steel.
